The effect of amantadine on neuroleptic-induced parkinsonism.
D000328:Adult; D000547:Amantadine / Q000627:therapeutic use*; D014150:Antipsychotic Agents; D002090:Butyrophenones; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy*; D010640:Phenothiazines
D014150:Antipsychotic Agents; D002090:Butyrophenones; D010640:Phenothiazines; D000547:Amantadine